Neuroimmunomodulatory properties of laquinimod
Laquinimod (ABR-215062) is a quinolone-3-carboxamide derivative, which is an orally active immunostimulatory drug molecule and is being developed for multiple sclerosis cases like relapsing-remitting multiple sclerosis (RRMS) and chronic progressive multiple sclerosis (CPMS). Laquinimod may mediate...
المؤلفون الرئيسيون: | , , |
---|---|
التنسيق: | مقال |
اللغة: | English |
منشور في: |
Elsevier
2024-03-01
|
سلاسل: | Brain Disorders |
الموضوعات: | |
الوصول للمادة أونلاين: | http://www.sciencedirect.com/science/article/pii/S2666459324000040 |